SwitzerlandMarket Access for Product-Registration in Switzerland
Navigating the complexities of global product registration requires a robust market access strategy. We empower life sciences companies to secure optimal market entry, accelerate time-to-market, and maximize commercial potential across diverse internation
6 Pillars of Effective Global Market Access
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
Global Regulatory Intelligence
Thorough analysis of the heterogeneous regulatory landscapes across target markets to identify optimal registration pathways and potential challenges. We provide clarity on requirements from FDA, EMA, PMDA, and other key authorities.
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Discovery & Landscape Assessment
We begin with a comprehensive analysis of your product, target indications, and desired global markets. This involves a deep dive into regulatory requirements, competitive landscape, and payer environments.
Market Overview: Global Product Registration & Market Access
Increasing Regulatory Divergence
The global regulatory landscape is becoming increasingly fragmented, with distinct requirements for evidence, pricing, and labeling across major markets. Navigating this complexity demands specialized expertise to avoid costly delays.
Value-Based Healthcare Imperative
Payer systems worldwide are shifting towards value-based assessments, requiring robust health economic evidence and real-world data at the point of registration. Products must demonstrate clear clinical and economic benefits to secure favorable reimbursement.
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic recommendations for market entry, pricing, reimbursement, and stakeholder engagement across your target geographies.
Regulatory Pathway & Reimbursement Roadmap
A detailed, region-specific roadmap illustrating optimal regulatory submission pathways and anticipated reimbursement processes, including key milestones and potential challenges.
Value Dossier & HTA Submission Framework
A structured framework and support for developing a compelling value dossier, tailored to meet the evidence requirements of various Health Technology Assessment (HTA) bodies globally.
Stakeholder Engagement & Advocacy Plan
A strategic plan identifying key opinion leaders, patient groups, and payer organizations, along with recommended engagement tactics to build support for your product.
Use Cases
First Global Launch of a Novel Therapy
A biotech startup with a groundbreaking oncology therapy sought to launch simultaneously in the US, EU, and Japan. Taevas provided integrated regulatory and market access strategy, ensuring aligned evidence generation and submission packages across all regions.
Related Services
Frequently Asked Questions
Ready to Secure Optimal Market Access for Your Product Globally?
Partner with Taevas Life Sciences to transform your global product registration challenges into strategic market successes.